Mammogen appoints Dr. Elise Berman as Chief Medical Officer to enhance RNA diagnostics for breast cancer detection. Contact us for more info.
Mammogen secures $30M to advance RNA diagnostics for breast cancer. Contact us to learn more about our innovative solutions.
Mammogen appoints Denise DeMan as Chairwoman. Learn how her leadership will enhance women's health diagnostics.
Mammogen & Brilliantly are giving away 50 heated bra inserts for women post-reconstructive surgery. Join us in supporting breast cancer care!
Mammogen is recognised for its RNA-powered diagnostics in women's health. Explore their awards & innovations in breast cancer detection.
Mammogen & Brilliantly enhance support for breast cancer previvors & survivors through innovative initiatives. Join us in empowering the community.